CN219558467U - Control system of comprehensive physiotherapy device - Google Patents

Control system of comprehensive physiotherapy device Download PDF

Info

Publication number
CN219558467U
CN219558467U CN202222232977.9U CN202222232977U CN219558467U CN 219558467 U CN219558467 U CN 219558467U CN 202222232977 U CN202222232977 U CN 202222232977U CN 219558467 U CN219558467 U CN 219558467U
Authority
CN
China
Prior art keywords
module
central control
control module
work
transistor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202222232977.9U
Other languages
Chinese (zh)
Inventor
周学武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Youran Biotechnology Co ltd
Original Assignee
Shenzhen Youran Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Youran Biotechnology Co ltd filed Critical Shenzhen Youran Biotechnology Co ltd
Priority to CN202222232977.9U priority Critical patent/CN219558467U/en
Application granted granted Critical
Publication of CN219558467U publication Critical patent/CN219558467U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P90/00Enabling technologies with a potential contribution to greenhouse gas [GHG] emissions mitigation
    • Y02P90/02Total factory control, e.g. smart factories, flexible manufacturing systems [FMS] or integrated manufacturing systems [IMS]

Abstract

The utility model is suitable for the field of physiotherapy systems, and provides a control system of a comprehensive physiotherapy device, which comprises a central control module for coordinating the work of each module and carrying out data processing, an electrotherapy module connected with the central control module and used for receiving work instructions and carrying out electrotherapy work, a phototherapy module connected with the central control module and used for receiving work instructions and carrying out phototherapy work, a medicine evaporation module connected with the central control module and used for receiving work instructions and carrying out medicine evaporation work, an input transmission module connected with the central control module, and a display transmission module connected with the central control module. The physical physiotherapy device aims at solving the technical problems that in physiotherapy products in the prior art, most of physical physiotherapy is carried out, such as external force pressing, vibration, knocking, rolling, electronic pulse potential waveform stimulation and the like, the physical physiotherapy can play a certain role in relieving, but the effect is not obvious.

Description

Control system of comprehensive physiotherapy device
Technical Field
The utility model belongs to the field of physiotherapy systems, and particularly relates to a control system of a comprehensive physiotherapy device.
Background
Physiotherapy is a physical treatment means of traditional Chinese medicine, and aims to achieve the purposes of local expansion of blood vessels, blood circulation enhancement and cell activity improvement by stimulating human body acupoints, thereby achieving the purposes of disease prevention and treatment. The prior meridian physiotherapy apparatus has various styles, such as external force pressing, vibration, knocking, rolling, electronic pulse potential waveform stimulation and the like, and has various advantages when used, however, the massage apparatus in the forms of vibration, knocking, rolling and the like acts on physiotherapy parts to play a role in treatment and health care, and has very little effect on accurate massage treatment and health care. The external force pressing mainly comprises finger pressing and tool pressing, the finger pressing and the tool pressing can be used alternately according to force requirements of different parts, the pertinence is high, the treatment effect is outstanding, the external force pressing is the most traditional physiotherapy means, only a doctor needs to pay great labor, the external force pressing is very hard, and the effect is often affected due to insufficient force.
At present, most of the physical physiotherapy products are subjected to physical physiotherapy, such as external force pressing, vibration, knocking, rolling, electronic pulse potential waveform stimulation and the like, and the physical physiotherapy can play a certain role in relieving, but the effect is not obvious.
Disclosure of Invention
The utility model aims to provide a control system of a comprehensive physiotherapy device, which aims to solve the technical problems that in the prior art, most physiotherapy products are subjected to physical physiotherapy, such as external force pressing, vibration, knocking, rolling, electronic pulse potential waveform stimulation and the like, and the physical physiotherapy can play a certain role in relieving, but the effect is not obvious.
The utility model is realized in such a way, the control system of the comprehensive physiotherapy device comprises a central control module which coordinates the work of each module and carries out data processing, an electrotherapy module which is connected with the central control module and is used for receiving work instructions and carrying out electrotherapy work, a phototherapy module which is connected with the central control module and is used for receiving work instructions and carrying out phototherapy work, a medicine evaporation module which is connected with the central control module and is used for receiving work instructions and carrying out medicine evaporation work, an input transmission module which is connected with the central control module and is used for transmitting control instructions of external equipment, and a display transmission module which is connected with the central control module and is used for transmitting execution conditions and work conditions to external display equipment for displaying.
The utility model further adopts the technical scheme that: the control system also comprises a low-frequency negative pressure module which is connected with the central control module and used for receiving the working instruction and carrying out low-frequency negative pressure work.
The utility model further adopts the technical scheme that: the control system also comprises an over-frequency module which is connected with the central control module and used for receiving the working instruction and performing over-frequency work.
The utility model further adopts the technical scheme that: the control system also comprises a superconducting module which is connected with the central control module and used for receiving the working instruction and performing superconducting work.
The utility model further adopts the technical scheme that: the central control module comprises a central processor U8 and a first peripheral circuit for assisting the central processor U8 to stably work.
The utility model further adopts the technical scheme that: the electrotherapy module comprises a triode Q10 which receives a working instruction of the central control module and works, a boosting circuit which is connected with the triode Q10 and consists of an inductor L5, a diode D5 and a capacitor C27 and used for boosting is controlled by the triode Q10, a first discharge electrotherapy circuit which consists of a triode Q1, a triode Q4 and a triode Q9 and a second discharge electrotherapy circuit which consists of a triode Q2, a triode Q5 and a triode Q8 are connected with the boosting circuit, and a second peripheral circuit which assists the triode Q10, the boosting circuit, the first discharge electrotherapy circuit and the second discharge electrotherapy circuit to work stably.
The utility model further adopts the technical scheme that: the phototherapy module comprises a field effect tube Q16 which receives the working instruction of the central control module and conducts the working, a plurality of light emitting diodes which are connected with the field effect tube Q16 and used for phototherapy, and a third peripheral circuit which assists the field effect tube Q16 and the light emitting diodes to work stably.
The utility model further adopts the technical scheme that: the medicine evaporation module comprises a field effect tube Q18 which receives a working instruction of the central control module and conducts work, a thermal resistor R28 which is connected with the field effect tube Q18 and used for medicine evaporation, and a fourth peripheral circuit which assists the field effect tube Q18 and the thermal resistor R28 to work stably.
The utility model further adopts the technical scheme that: the low-frequency negative pressure module comprises a field effect tube Q11 and a field effect tube Q12 which receive the working instruction of the central control module and conduct the working, a low-frequency device PUP1 which is connected with the field effect tube Q11 and used for generating low frequency, a negative pressure device KP1 which is connected with the field effect tube Q12 and used for generating negative pressure, and a fifth peripheral circuit which assists the field effect tube Q11, the field effect tube Q12, the low-frequency device PUP1 and the negative pressure device KP1 to work stably.
The utility model further adopts the technical scheme that: the over-frequency module comprises a triode Q7 and a triode Q3 which receive the working instruction of the central control module and conduct work, an oscillating circuit which is connected with the triode Q3 and is formed by an inductor L2, an inductor L3 and a capacitor 17 and used for generating over-frequency voltage, a port CV1 which is connected with the oscillating circuit and used for outputting the over-frequency voltage, and a sixth peripheral circuit which assists the triode Q7, the triode Q3, the oscillating circuit and the port CV1 to work stably; the superconducting module comprises a chip U5 which receives the working instruction of the central control module and works, a super-effect tube Q14 which is connected with the chip U5 and used for receiving the working instruction and conducting the working, a transformer TR1 which is connected with the super-effect tube Q14 and used for transforming, superconducting equipment RF1 which is connected with the transformer TR1 and used for generating superconducting, and a seventh peripheral circuit which assists the chip U5, the super-effect tube Q14, the transformer TR1 and the superconducting equipment RF1 to work stably; the input transmission module comprises a serial port connected with external equipment and an eighth peripheral circuit for assisting the serial port to work; the display transmission module comprises a chip U6 which receives and works by the working instruction of the central control module, and a ninth peripheral circuit which assists the chip U6 to work stably.
The beneficial effects of the utility model are as follows: the control system of the comprehensive physiotherapy device is characterized in that the physical physiotherapy is added with the medicine physiotherapy, the medicine is evaporated and decomposed through the medicine evaporation module, and the medicine is quickly permeated into skin through pressing, vibration, knocking, rolling and electronic pulse potential waveform stimulation, so that the manual massage effect of a doctor can be replaced, various forces and intensity can be adjusted, and the control system is convenient to use, and is time-saving and labor-saving.
Drawings
FIG. 1 is a system block diagram of a control system of an integrated physiotherapy apparatus according to an embodiment of the present utility model;
FIG. 2 is an electrical schematic diagram of a central control module of a control system of an integrated physiotherapy device according to an embodiment of the present utility model;
FIG. 3 is an electrical schematic diagram of an electrotherapy module of a control system of an integrated physiotherapy device according to an embodiment of the present utility model;
FIG. 4 is an electrical schematic diagram of a phototherapy module of a control system of an integrated physiotherapy device according to an embodiment of the present utility model;
FIG. 5 is an electrical schematic diagram of a drug evaporation module of a control system of an integrated physiotherapy device according to an embodiment of the present utility model;
FIG. 6 is an electrical schematic diagram of a low frequency negative pressure module of a control system of a comprehensive physiotherapy device according to an embodiment of the present utility model;
FIG. 7 is an electrical schematic diagram of an over-frequency module of a control system of a comprehensive physiotherapy device according to an embodiment of the present utility model;
FIG. 8 is an electrical schematic diagram of a superconducting module of a control system of an integrated physiotherapy device according to an embodiment of the present utility model;
FIG. 9 is an electrical schematic diagram of an input transmission module of a control system of an integrated physiotherapy device according to an embodiment of the present utility model;
fig. 10 is an electrical schematic diagram of a display and transmission module of a control system of an integrated physiotherapy device according to an embodiment of the present utility model.
Detailed Description
Fig. 1 to 10 show a control system of an integrated physiotherapy device provided by the utility model, wherein the control system comprises a central control module for coordinating the work of each module and performing data processing, an electrotherapy module connected with the central control module and used for receiving work instructions and performing electrotherapy work, a phototherapy module connected with the central control module and used for receiving work instructions and performing phototherapy work, a medicine evaporation module connected with the central control module and used for receiving work instructions and performing medicine evaporation work, an input transmission module connected with the central control module and used for transmitting control instructions of external equipment, and a display transmission module connected with the central control module and used for transmitting execution conditions and work conditions to external display equipment for displaying.
The central control module includes a central processor U8, and a first peripheral circuit that assists the central processor U8 in stabilizing operation, as shown in fig. 2. The central processing unit U8 receives and analyzes the control signals of the external equipment, and sends the control signals to each module after the control signals are completed so as to control each module to perform corresponding work.
As shown in fig. 3, the electrotherapy module includes a triode Q10 that receives the working instruction of the central control module and works, and is connected to the triode Q10 to boost the voltage by controlling a boost circuit composed of an inductor L5, a diode D5 and a capacitor C27 by the triode Q10, and is connected to a first discharge electrotherapy circuit composed of a triode Q1, a triode Q4 and a triode Q9, a second discharge electrotherapy circuit composed of a triode Q2, a triode Q5 and a triode Q8, and a second peripheral circuit that assists the triode Q10, the boost circuit, the first discharge electrotherapy circuit and the second discharge electrotherapy circuit to work stably. After receiving an electrotherapy working instruction sent by external equipment, a central processing unit U8 receives the instruction and analyzes the instruction, after analysis, the central processing unit U8 controls a P2.13 pin to output PWM pulse to control a triode Q10 to work, a boosting circuit consisting of an inductor L5, a diode D5 and a capacitor C27 is boosted under PWM pulse control, after boosting, a discharging circuit consisting of 6 three-stage pipes of Q1, Q2, Q4, Q5, Q8 and Q9 is discharged, when the P2.12 pin of the central processing unit U8 outputs a high level and the P2.11 pin outputs a low level, Q9, Q1 and Q4 are conducted, and Q8, Q2 and Q5 are cut off, and the first discharging electrotherapy circuit outputs a high voltage; when the pin P2.12 of the CPU U8 outputs a low level and the pin P2.11 outputs a high level, the Q9, Q1 and Q4 are turned off, the Q8, Q2 and Q5 are turned on, and the second discharge electrotherapy circuit outputs a high voltage, so that the switching is realized to output the high voltage.
As shown in fig. 4, the phototherapy module includes a field effect tube Q16 that receives the working instruction of the central control module and conducts the working, a plurality of light emitting diodes connected to the field effect tube Q16 for phototherapy, and a third peripheral circuit that assists the field effect tube Q16 and the plurality of light emitting diodes to work stably. After receiving the phototherapy operation instruction sent by the external equipment, the central processing unit U8 receives the instruction and analyzes the instruction, and after the analysis is completed, the central processing unit U8 controls the P2.5 pin to output high level, and then controls the field effect transistor Q16 to conduct work, so that a plurality of light emitting diodes emit light to perform phototherapy work.
As shown in fig. 5, the drug evaporation module includes a field effect transistor Q18 that receives the working command of the central control module and conducts the work, a thermal resistor R28 that is connected to the field effect transistor Q18 and used for drug evaporation, and a fourth peripheral circuit that assists the stable work of the field effect transistor Q18 and the thermal resistor R28. After receiving a medicine evaporation working instruction sent by external equipment, the central processing unit U8 receives the instruction and analyzes the instruction, and after analysis is completed, the central processing unit U8 controls the P0.3 pin to output a high level, so as to control the field effect transistor Q18 to conduct work, and the thermal resistor R28 heats to carry out external medicine evaporation work.
The control system further comprises a low frequency negative pressure module connected to the central control module for receiving the operating command and performing a low frequency negative pressure operation as shown in fig. 6. The low-frequency negative pressure module comprises a field effect tube Q11 and a field effect tube Q12 which receive the working instruction of the central control module and conduct the working, a low-frequency device PUP1 which is connected with the field effect tube Q11 and used for generating low frequency, a negative pressure device KP1 which is connected with the field effect tube Q12 and used for generating negative pressure, and a fifth peripheral circuit which assists the field effect tube Q11, the field effect tube Q12, the low-frequency device PUP1 and the negative pressure device KP1 to work stably. After receiving a low-frequency negative pressure working instruction sent by external equipment, the central processing unit U8 receives the instruction and analyzes the instruction, and after analysis is completed, the central processing unit U8 controls the P0.4 pin and the P0.5 pin to output high level, so as to control the field effect tube Q11 and the field effect tube Q12 to conduct work, and the low-frequency equipment PUP1 and the negative pressure equipment KP1 are enabled to conduct low-frequency negative pressure work.
The control system further includes an over-frequency module connected to the central control module for receiving the work instruction and performing over-frequency operation, as shown in fig. 7. The over-frequency module comprises a triode Q7 and a triode Q3 which receive the working instruction of the central control module and conduct the working, an oscillating circuit which is connected with the triode Q3 and is used for generating over-frequency voltage and composed of an inductor L2, an inductor L3 and a capacitor 17, a port CV1 which is connected with the oscillating circuit and is used for outputting the over-frequency voltage, and a sixth peripheral circuit which assists the triode Q7, the triode Q3, the oscillating circuit and the port CV1 to work stably. After receiving the over-frequency working instruction sent by the external equipment, the central processing unit U8 receives the instruction and analyzes the instruction, the central processing unit U8 controls the P2.0 pin to output the PWM pulse circuit after analysis is completed, the triode Q7 and the triode Q3 are controlled to be conducted or closed at high frequency, the inductance L2, the inductance L3 and the capacitor C17 oscillating circuit generate over-frequency voltage, and then the over-frequency voltage is output by the port CV1 to enter the over-frequency working.
The control system also includes a superconducting module coupled to the central control module for receiving the operating instructions and performing superconducting operations, as shown in fig. 8. The superconducting module comprises a chip U5 which receives the working instruction of the central control module and works, a super-effect tube Q14 which is connected with the chip U5 and used for receiving the working instruction and conducting the working, a transformer TR1 which is connected with the super-effect tube Q14 and used for transforming, superconducting equipment RF1 which is connected with the transformer TR1 and used for generating superconducting, and a seventh peripheral circuit which assists the chip U5, the super-effect tube Q14, the transformer TR1 and the superconducting equipment RF1 to work stably. After receiving the over-frequency working instruction sent by the external equipment, the central processing unit U8 receives the instruction and analyzes the instruction, the central processing unit U8 controls the P0.8 pin to output a high level after the analysis is completed, the control chip U5 starts working, and after the chip U5 receives the starting level of the central processing unit U8, the chip U5 outputs a PWM pulse level, so that the superconducting work is started.
As shown in fig. 9, the input transmission module includes a serial port connected to an external device, and an eighth peripheral circuit for assisting the serial port to operate; the P2 or P6 serial port receives the serial port control instruction input by the external device and transmits the serial port control instruction to the CPU U8, namely, the control instruction transmission is completed.
As shown in fig. 10, the display transmission module includes a chip U6 that receives the operation command of the central control module and operates, and a ninth peripheral circuit that assists the chip U6 in stably operating. The chip U6 of the display transmission module can realize Bluetooth data transmission, and in addition, the chip U6 can transmit the execution condition of each module back to the external display equipment for working condition display.
The control system of the comprehensive physiotherapy device is characterized in that the physical physiotherapy is added with the medicine physiotherapy, the medicine is evaporated and decomposed through the medicine evaporation module, and the medicine is quickly permeated into skin through pressing, vibration, knocking, rolling and electronic pulse potential waveform stimulation, so that the manual massage effect of a doctor can be replaced, various forces and intensity can be adjusted, and the control system is convenient to use, and is time-saving and labor-saving.
The foregoing description of the preferred embodiments of the utility model is not intended to be limiting, but rather is intended to cover all modifications, equivalents, and alternatives falling within the spirit and principles of the utility model.

Claims (10)

1. The control system of the comprehensive physiotherapy device is characterized by comprising a central control module for coordinating the work of each module and carrying out data processing, an electrotherapy module connected with the central control module and used for receiving work instructions and carrying out electrotherapy work, a phototherapy module connected with the central control module and used for receiving work instructions and carrying out phototherapy work, a medicine evaporation module connected with the central control module and used for receiving work instructions and carrying out medicine evaporation work, an input transmission module connected with the central control module and used for transmitting control instructions of external equipment, and a display transmission module connected with the central control module and used for transmitting execution conditions and work conditions to external display equipment for displaying.
2. The control system of claim 1, further comprising a low frequency negative pressure module coupled to the central control module for receiving a work order and performing a low frequency negative pressure operation.
3. The control system of any of claims 1-2, further comprising an over-frequency module coupled to the central control module for receiving the operating instructions and performing over-frequency operation.
4. A control system according to claim 3, further comprising a superconducting module connected to the central control module for receiving the operating instructions and performing superconducting operations.
5. The control system of claim 1, wherein the central control module comprises a central processor U8 and a first peripheral circuit that assists the central processor U8 in stabilizing operation.
6. The control system according to any one of claims 2 or 5, wherein the electrotherapy module includes a transistor Q10 that receives an operation instruction of the central control module and operates, a boost circuit that is connected to the transistor Q10 and is configured to boost voltage by the transistor Q10 and is configured to control the voltage of the boost circuit including an inductor L5, a diode D5, and a capacitor C27, a first discharge electrotherapy circuit that is connected to the boost circuit and is configured to include a transistor Q1, a transistor Q4, and a transistor Q9, a second discharge electrotherapy circuit that is configured to include a transistor Q2, a transistor Q5, and a transistor Q8, and a second peripheral circuit that is configured to assist the transistor Q10, the boost circuit, the first discharge electrotherapy circuit, and the second discharge electrotherapy circuit to operate stably.
7. The control system of claim 1, wherein the phototherapy module includes a field effect transistor Q16 that receives the operation command of the central control module and conducts the operation, a plurality of light emitting diodes connected to the field effect transistor Q16 for phototherapy, and a third peripheral circuit that assists the stable operation of the field effect transistor Q16 and the plurality of light emitting diodes.
8. The control system of claim 1, wherein the drug evaporation module comprises a field effect transistor Q18 receiving the operation command of the central control module and conducting the operation, a thermal resistor R28 connected to the field effect transistor Q18 for drug evaporation, and a fourth peripheral circuit assisting the stable operation of the field effect transistor Q18 and the thermal resistor R28.
9. The control system according to claim 2, wherein the low-frequency negative pressure module includes a field effect transistor Q11 and a field effect transistor Q12 that receive the operation instruction of the central control module and conduct the operation, a low-frequency device PUP1 that is connected to the field effect transistor Q11 for generating a low frequency, a negative pressure device KP1 that is connected to the field effect transistor Q12 for generating a negative pressure, and a fifth peripheral circuit that assists the stable operation of the field effect transistor Q11, the field effect transistor Q12, the low-frequency device PUP1, and the negative pressure device KP 1.
10. The control system according to claim 4, wherein the over-frequency module comprises a transistor Q7 and a transistor Q3 which receive the operation command of the central control module and are turned on, an oscillating circuit which is connected with the transistor Q3 and is composed of an inductor L2, an inductor L3 and a capacitor 17 and is used for generating an over-frequency voltage, a port CV1 which is connected with the oscillating circuit and is used for outputting the over-frequency voltage, and a sixth peripheral circuit which assists the transistor Q7, the transistor Q3, the oscillating circuit and the port CV1 to stably operate; the superconducting module comprises a chip U5 which receives the working instruction of the central control module and works, a super-effect tube Q14 which is connected with the chip U5 and used for receiving the working instruction and conducting the working, a transformer TR1 which is connected with the super-effect tube Q14 and used for transforming, superconducting equipment RF1 which is connected with the transformer TR1 and used for generating superconducting, and a seventh peripheral circuit which assists the chip U5, the super-effect tube Q14, the transformer TR1 and the superconducting equipment RF1 to work stably; the input transmission module comprises a serial port connected with external equipment and an eighth peripheral circuit for assisting the serial port to work; the display transmission module comprises a chip U6 which receives and works by the working instruction of the central control module, and a ninth peripheral circuit which assists the chip U6 to work stably.
CN202222232977.9U 2022-08-24 2022-08-24 Control system of comprehensive physiotherapy device Active CN219558467U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202222232977.9U CN219558467U (en) 2022-08-24 2022-08-24 Control system of comprehensive physiotherapy device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202222232977.9U CN219558467U (en) 2022-08-24 2022-08-24 Control system of comprehensive physiotherapy device

Publications (1)

Publication Number Publication Date
CN219558467U true CN219558467U (en) 2023-08-22

Family

ID=87668742

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202222232977.9U Active CN219558467U (en) 2022-08-24 2022-08-24 Control system of comprehensive physiotherapy device

Country Status (1)

Country Link
CN (1) CN219558467U (en)

Similar Documents

Publication Publication Date Title
CN108744275A (en) A kind of wearable transcutaneous electrical stimulation medical apparatus for treating menalgia
CN203154605U (en) Portable constant-pulse-current parturition analgesia instrument
CN103157197B (en) A kind of ultrasonic therapeutic apparatus
CN103272331A (en) Intelligent digital multifunctional therapeutic apparatus mainly used for treating intestinal adhesion
CN206138166U (en) Intelligence blood vessel protection appearance with plant neuroregulation function
CN219558467U (en) Control system of comprehensive physiotherapy device
CN201022908Y (en) USB low frequency physiotherapy equipment
CN205307623U (en) Mammary gland therapeutic instrument
CN201179281Y (en) MM wave therapeutic instrument
CN115337529A (en) Control system of comprehensive physiotherapy device
KR20050102615A (en) Low frequency, supersonic waves, color therapy all style probe
CN204601384U (en) There is the high electrograph therapy instrument of four kinds of different distorted waveforms
CN104107503A (en) Intermediate-frequency-modulated low frequency sonophoresis system
CN205460472U (en) Traditional chinese medical science transdermal electrotherapy circuit
CN210044701U (en) Electronic acupuncture therapeutic instrument
CN219764328U (en) Circuit structure of beauty instrument
CN211299918U (en) Acupoint diagnosis device
CN210168268U (en) Radiation frequency regulating circuit of infrared brain cell physiotherapy instrument
CN113262040A (en) Tumor ablation equipment using ultrahigh-voltage positive-negative composite pulse electric field
CN201519385U (en) Ultrasonic prostate therapeutic apparatus
CN213964321U (en) Acupoint diagnosis and treatment instrument
CN1150949C (en) Therapeutic instrument for treating pelvic inflammation
CN202740634U (en) Hair growth promoting instrument
CN201171861Y (en) Bionic electric therapeutic apparatus
CN204337520U (en) Bioelectric resonance pain therapeutic equipment

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant